Brief: Lipigon Announces Development, License Agreement For Drug Candidate Lipisense

Lipigon Pharmaceuticals AB

27/06/2023 07:44

June 27 (Reuters) - Lipigon Pharmaceuticals AB  LPGO.ST :
    * ANNOUNCES DEVELOPMENT AND LICENSE AGREEMENT WITH LEADERNA FOR ITS DRUG CANDIDATE LIPISENSE
    * LEADERNA WILL BE RESPONSIBLE FOR DEVELOPMENT AND COMMERCIALIZATION OF LIPISENSE^® IN
GREATER
CHINA
    * WILL RECEIVE AN UPFRONT PAYMENT AND MAY RECEIVE MILESTONE PAYMENTS PLUS ROYALTIES ON SALES
UP TO
A TOTAL OF USD $91 MILLION

Source text for Eikon:  ID:nBQN4rdXmf 
Further company coverage:  LPGO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))